Drugs / Nektar 118
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01533155 Comparator | Mar → Sep 2012 | constipation disorder | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nektar 118 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01533155 ↗ |
| Route | Oral | “Oral 25 mg tablet” NCT01533155 ↗ |